Researchers at the University of Illinois at Chicago and AbbVie Inc. have developed a novel device that will help scientists and pharmaceutical companies more effectively screen and test formation of drug substance — active pharmaceutical ingredient (API).
Source: EurekaAlert, https://www.eurekalert.org